Schreiner, Philipp http://orcid.org/0000-0003-1610-1925
Balcar, Lorenz
Schlager, Hansjörg
Madl, Christian
Ziachehabi, Alexander
Mader, Markus
Steidl, Karin
Dinkhauser, Patrick
Reider, Simon
Dolak, Werner
Dejaco, Clemens
Gröchenig, Hans Peter
Novacek, Gottfried
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 28 January 2023
Accepted: 19 March 2023
First Online: 18 April 2023
Conflict of interest
: P. Schreiner received consulting fees from Falk Pharma, Sanofi, Galapagos, Pfizer, Takeda, Abbvie, Janssen-Cilag and Ferring. H. Schlager received consulting fees from Falk Pharma and MedTronic. G. Novacek has received consulting fees from AbbVie, MSD, Takeda, Janssen, Sandoz, Pfizer, Astro Pharma, Falk Pharma, Ferring, Gilead, Galapagos and Vifor. L. Balcar, C. Madl, A. Ziachehabi, M. Mader, K. Steidl, P. Dinkhauser, S. Reider, W. Dolak, C. Dejaco, and H. P. Gröchenig declare that they have no competing interests.